Open Label , Randomized, Three Arm Parallel Group Single Dose Comparative Pharmacokinetic , Safety and Immunogenicity Study in Healthy Subjects

NCT06929039 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis (RA

Interventions

DRUG: Abatacept
DRUG: Abatacept
DRUG: Abatacept

Sponsor

Kashiv BioSciences, LLC